Difficulty: Medium
Average Score: 87%
Practice
A 47-year-old man presents to the ambulatory care center with symptoms of hypoglycemia and is found to have an insulinoma. His medical history is significant for occasional asthma, which he treats using an albuterol inhaler, and an MI for which he takes daily low-dose aspirin. Because he takes aspirin, he is not able to immediately undergo surgery. The physician prescribes diazoxide for therapy until the tumor can be removed. Diazoxide stimulates potassium channels leading to inhibition of insulin release. Which of the following is most likely to occur in this patient as a result of diazoxide therapy?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Hypotension. Diazoxide, by stimulating potassium channels, inhibits insulin release. Insulinoma causes excessive insulin production, leading to hypoglycemia. By inhibiting insulin release, diazoxide helps counteract the hypoglycemic effects in this patient.
Option A) Bronchoconstriction is incorrect because diazoxide, by inhibiting insulin release, does not directly cause bronchoconstriction.
Option B) Hypertension is incorrect because diazoxide, although it can cause fluid retention leading to edema, is more commonly associated with hypotension due to its vasodilatory effects.
Option C) Hypoglycemia is incorrect in this case because diazoxide helps prevent hypoglycemia by inhibiting insulin release in a patient with an insulinoma.
Educationally, understanding the pharmacological actions of diazoxide in inhibiting insulin release and its effects on potassium channels is crucial in managing patients with conditions like insulinoma. This knowledge helps in selecting appropriate therapies and anticipating potential side effects like hypotension. It highlights the importance of individualized treatment plans based on the patient's unique medical history and current medications.
Option A) Bronchoconstriction is incorrect because diazoxide, by inhibiting insulin release, does not directly cause bronchoconstriction.
Option B) Hypertension is incorrect because diazoxide, although it can cause fluid retention leading to edema, is more commonly associated with hypotension due to its vasodilatory effects.
Option C) Hypoglycemia is incorrect in this case because diazoxide helps prevent hypoglycemia by inhibiting insulin release in a patient with an insulinoma.
Educationally, understanding the pharmacological actions of diazoxide in inhibiting insulin release and its effects on potassium channels is crucial in managing patients with conditions like insulinoma. This knowledge helps in selecting appropriate therapies and anticipating potential side effects like hypotension. It highlights the importance of individualized treatment plans based on the patient's unique medical history and current medications.